ArticleBMC cancer2008

TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.

Jolanta Kupryjanczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.